PharmaShots | Incisive News in 3 Shots

Subscribe Now

Acute Treatment of Migrane

Lilly Files Lasmiditan to FDA for Acute Treatment of Migrane

Lilly Files Lasmiditan to FDA for Acute Treatment of Migrane

November 15, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us